Oxymetholone
Structural formula | ||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
![]() |
||||||||||||||||||||||
General | ||||||||||||||||||||||
Non-proprietary name | Oxymetholone | |||||||||||||||||||||
other names |
|
|||||||||||||||||||||
Molecular formula | C 21 H 32 O 3 | |||||||||||||||||||||
Brief description |
whitish, odorless, crystalline powder |
|||||||||||||||||||||
External identifiers / databases | ||||||||||||||||||||||
|
||||||||||||||||||||||
Drug information | ||||||||||||||||||||||
ATC code | ||||||||||||||||||||||
properties | ||||||||||||||||||||||
Molar mass | 332.48 g · mol -1 | |||||||||||||||||||||
Physical state |
firmly |
|||||||||||||||||||||
Melting point |
178-180 ° C |
|||||||||||||||||||||
solubility |
|
|||||||||||||||||||||
safety instructions | ||||||||||||||||||||||
|
||||||||||||||||||||||
Toxicological data | ||||||||||||||||||||||
As far as possible and customary, SI units are used. Unless otherwise noted, the data given apply to standard conditions . |
Oxymetholone is a synthetic drug selected from the group of the anabolic steroids and is a derivative ( derivative ) of the physiologically occurring sex hormone dihydrotestosterone .
history
Oxymetholone was developed and marketed by the Syntex company in 1960 . The field of application at that time was in the treatment of anemia , as the active ingredient has the ability to increase the number of red blood cells. Syntex stopped producing the product in 1993, as newer active ingredients had proven to be more effective and better tolerated in the treatment of anemia. In 1998, oxymetholone was temporarily re-launched on the market by the pharmaceutical company Unimed , as it had proven to be an effective means of increasing body weight in diseases such as AIDS , which are associated with severe weight loss.
Mode of action
As a derivative of dihydrotestosterone (DHT), oxymetholone cannot convert to estrogen in the human body , but in contrast to DHT, it does cause fat tissue to accumulate and water to be stored in the body. The reason for this is an activation of estrogen receptors by oxymetholone and the resulting estrogen-typical effects. Oxymetholone also stimulates the formation and development of red blood cells ( erythropoiesis ).
Abuse in Sports
Oxymetholone is known as a doping agent mainly under the name Anapolon. Due to its pronounced anabolic and androgenic effects, it is abused by doping strength athletes, bodybuilders, wrestlers, boxers, etc. to achieve a rapid increase in strength. It is considered to be one of the most effective, but also most harmful steroids. An effect already occurs after the first dose.
Since 2005 oxymetholone is on the prohibited list The 2005 Prohibited List of the World Anti-Doping Agency ( WADA ). Possession of more than 100 mg is assessed as a not small amount according to the German Medicines Act , according to the doping agent quantity regulation .
Side effects
Oxymetholone has a number of side effects, including:
- Liver dysfunction (studies suggest liver cancer with prolonged use)
- Jaundice
- Increase in blood pressure
- oily skin and severe acne
- Accelerated hair loss that cannot be treated with finasteride
- strong headache
- nausea
- Vomit
- stomach pain
- insomnia
- diarrhea
- Epistaxis
- general malaise
- heavy sweating
- Worsening of blood lipids
- impaired thyroid function
swell
- D. Sinner, Anabolic Steroids. The Black Book 2007 , BMS-Verlag, Gronau 2007. ISBN 978-3-00-020944-4 . Page 415/416.
- Page no longer available , search web archives: Official Anadrol-50 Site - Oral Anabolic Steroid FDA-approved for Anemia ) (
- Oxymetholone information at Rxlist.com
Individual evidence
- ↑ a b c d e entry on oxymetholone. In: Römpp Online . Georg Thieme Verlag, accessed on June 23, 2011.
- ↑ a b Oxymetholone data sheet from Sigma-Aldrich , accessed on May 9, 2017 ( PDF ).
- ↑ a b Entry on oxymetholone in the ChemIDplus database of the United States National Library of Medicine (NLM) .
- ^ JAMA, Journal of the American Medical Association. Vol. 240, p. 243, 1978.
- ↑ Drugs in Japan Vol. 6 , p. 156, 1982.
- ↑ FTW Publishing - Steroid Info Oxymetholone, 2006.